REVB Logo

Revelation Biosciences, Inc. (REVB) 

NASDAQ$3.4
Market Cap
$3.08M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
806 of 924
Rank in Industry
456 of 527

REVB Insider Trading Activity

REVB Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00
Sells
$00

Related Transactions

No records found

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a …

Insider Activity of Revelation Biosciences, Inc.

Over the last 12 months, insiders at Revelation Biosciences, Inc. have bought $0 and sold $0 worth of Revelation Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Revelation Biosciences, Inc. have bought $151,908 and sold $2.26M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $29,000 was made by TIDMARSH GEORGE F (director) on 2023‑04‑18.

List of Insider Buy and Sell Transactions, Revelation Biosciences, Inc.

2023-12-08SaleTIDMARSH GEORGE Fdirector
27,771
0.4059%
$0.52$14,438-88.48%
2023-10-16SaleTIDMARSH GEORGE Fdirector
12,802
0.1963%
$0.66$8,442-88.31%
2023-09-28SaleTIDMARSH GEORGE Fdirector
1,429
0.0232%
$0.69$986-88.01%
2023-09-18SaleTIDMARSH GEORGE Fdirector
4,000
0.0648%
$0.74$2,960-88.05%
2023-09-15SaleTIDMARSH GEORGE Fdirector
9,500
0.1449%
$0.73$6,935-88.60%
2023-09-14SaleTIDMARSH GEORGE Fdirector
12,000
0.1906%
$0.75$9,000-88.44%
2023-04-18PurchaseTIDMARSH GEORGE Fdirector
25,000
1.1925%
$1.16$29,000-38.61%
2023-04-17PurchaseTIDMARSH GEORGE Fdirector
26,500
1.1885%
$1.16$30,740-42.25%
2022-02-25PurchaseTIDMARSH GEORGE F
20,000
0.1609%
$1.60$32,000-70.03%
2022-02-09PurchaseTIDMARSH GEORGE F
30,000
0.2157%
$2.55$76,599-81.48%
2022-02-08PurchaseTIDMARSH GEORGE F
1,000
0.007%
$2.54$2,540-81.68%
2022-02-07PurchaseTIDMARSH GEORGE F
42,100
0.2939%
$2.61$109,780-82.13%
2022-02-04PurchaseTIDMARSH GEORGE F
9,900
0.0679%
$2.34$23,156-80.31%
2021-09-23SaleGLAZER CAPITAL, LLC10 percent owner
611,541
4.7291%
$10.08$6.16M-88.63%
2021-09-22SaleGLAZER CAPITAL, LLC10 percent owner
5
<0.0001%
$10.08$50-88.58%
2021-09-21SaleGLAZER CAPITAL, LLC10 percent owner
43,000
0.3323%
$10.08$433,440-88.59%
2020-11-09SaleGLAZER CAPITAL, LLC10 percent owner
5,000
0.0396%
$10.00$50,000+1388373.68%
2020-10-12SaleGLAZER CAPITAL, LLC10 percent owner
20
0.0002%
$10.00$200+1386811.84%
2020-10-09SaleGLAZER CAPITAL, LLC10 percent owner
9,328
0.0738%
$10.00$93,280+1386314.47%
Total: 19

REVB Institutional Investors: Active Positions

Increased Positions6+75%5,940+95.99%
Decreased Positions4-50%6,028-97.41%
New Positions5New5,926New
Sold Out Positions3Sold Out6,027Sold Out
Total Postitions10+25%6,100-1.42%

REVB Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Xtx Topco Ltd$11.000.31%3,115+3,115New2024-12-31
Two Sigma Securities, Llc$6.000.18%1,819+1,819New2024-12-31
Geode Capital Management, Llc$2.000.07%685+685New2024-12-31
Sbi Securities Co., Ltd.$1.000.03%301+301New2024-12-31
Tower Research Capital Llc (Trc)$1.000.02%158<1-0.63%2024-12-31
Bank Of America Corp /De/$0<0.01%16+14+700%2024-12-31
Royal Bank Of Canada$0<0.01%6+6New2024-12-31
Ubs Group Ag$00%0-2,559Sold Out2024-12-31
Sabby Management, Llc$00%0-2,639Sold Out2024-12-31
Susquehanna International Group, Llp$00%0-829Sold Out2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1Strong BuyBuyHoldSellStrong Sell